Solana

Solana P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Solana (HSDT) as of Oct 16, 2026 is -1.49. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -8.26 — a change of -81.98% (higher).

P/FCF

-1.49

YoY

-81.98%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Solana is 2025 -1.49 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Solana was 2024 -8.26 . It decreases by -81.98% higher compared to the previous year.

The Solana P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-4.55 USD
Jan 1, 2019
-4.29 USD
Jan 1, 2020
-7.73 USD
Jan 1, 2021
-6.79 USD
Jan 1, 2022
-6.37 USD
Jan 1, 2023
-8.74 USD
Jan 1, 2024
-8.26 USD
Jan 1, 2025
-1.49 USD
The Solana P/FCF history
YEARP/FCFYoY
-1.49-81.98%
-8.26-5.44%
-8.74+37.17%
-6.37-6.18%
-6.79-12.21%
-7.73+80.30%
-4.29-5.72%
-4.55-2.72%
-4.68-18.65%
-5.75-48.80%
-11.23+55.55%
-7.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Solana Stock analysis

What does Solana do? Solana Co, with ticker HSDT and ISIN US42328V8761, is a health care company based in Newtown, United States. The company has 21 employees and went public on June 27, 2014. Its website is https://heliusmedical.com/. Solana Co operates within the health care sector, focusing on neurological wellness through non-invasive medical technologies. The company develops, licenses, or acquires non-invasive platform technologies designed to enhance the brain's natural healing capabilities. While the source description mentions a product called the portable neuromodulation stimulator (PoNS) device, which is described as a class II medical device in Canada for treating balance deficits related to mild-to-moderate traumatic brain injury, Solana Co's profile does not confirm this product or its specific applications. The company's operations and product details are not elaborated beyond the provided information. Solana Co is headquartered in Newtown, Pennsylvania, and its primary focus remains on neurological wellness within the health care industry. The company's public listing date and employee count are the only financial and operational details available in the provided data. No additional acquisitions, founding year, or specific product names beyond the general description are confirmed in the factual information provided. Solana is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Solana stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Solana is -1.49 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Solana changed from -8.26 to -1.49, representing a -81.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Solana since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Solana with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Solana

All Key Metrics — Solana